SCHEMBL1016752

SCHEMBL1016752

CCN(CC)CC=CC(=O)N1CCc2c(sc3ncnc(Nc4ccc5c(ccn5Cc5cccc(F)c5)c4)c23)C1

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.57
MKNK1 Q9BUB5 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016750 1.00 EGFR (0.57) EGFRMKNK1
SCHEMBL1017142 0.95 EGFR (0.56) EGFRMKNK1
SCHEMBL1017144 0.95 EGFR (0.56) EGFRMKNK1
SCHEMBL1016523 0.94 EGFR (0.63) EGFRMKNK1
SCHEMBL1016525 0.94 EGFR (0.63) EGFRMKNK1
SCHEMBL3620439 0.93 EGFR (0.61) EGFR
SCHEMBL1014352 0.92 EGFR (0.60) EGFRMKNK1
SCHEMBL1014351 0.92 EGFR (0.60) EGFRMKNK1
SCHEMBL1017445 0.92 EGFR (0.65) EGFRMKNK1
SCHEMBL1017446 0.92 EGFR (0.65) EGFRMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed